Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.70 +0.01 (+1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Net Margin (2021 - 2022)

Updated

Milestone Pharmaceuticals (MIST) recorded Net Margin of -970.40% in Q3 2022.

Analysis

Milestone Pharmaceuticals (MIST) Net Margin (2021 - 2022) Analysis & Trends

On a TTM basis, Milestone Pharmaceuticals' Net Margin came in at -377.65% as of Sep 30, 2022; for FY2021, it came in at -285.69%.

  • The Q3 2022 figure is the highest quarterly Net Margin since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.83%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 21.27%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 22.65%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.30%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -134.51%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -1.65%
10 Milestone Pharmaceuticals 97.49 Mn -73.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -970.40%
Jun 30, 2022 -10,536.71%
Jun 30, 2021 5.13%
API Access

Milestone Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=MIST&period=max&api_key=YOUR_API_KEY